Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies
Highlights•Dementia involves the chronic and progressive deterioration of cognitive
functions.•Alzheimer's disease is the most common form of dementia.•Abnormally …
functions.•Alzheimer's disease is the most common form of dementia.•Abnormally …
[HTML][HTML] Metformin derivatives–Researchers' Friends or Foes?
ST Torunoglu, A Zajda, J Tampio… - Biochemical …, 2023 - Elsevier
Metformin has been used for ages to treat diabetes mellitus due to its safety profile and low
cost. However, metformin has variable pharmacokinetics in patients, and due to its poor oral …
cost. However, metformin has variable pharmacokinetics in patients, and due to its poor oral …
[HTML][HTML] Exploring the rhodanine universe: Design and synthesis of fluorescent rhodanine-based derivatives as anti-fibrillar and anti-oligomer agents against α …
AA Elbatrawy, TA Ademoye, H Alnakhala… - Bioorganic & medicinal …, 2024 - Elsevier
Tau and α-synuclein (α-syn) are prone-to-aggregate proteins that can be responsible for
pathological lesions found in the brains of Alzheimer's disease (AD), Lewy body dementia …
pathological lesions found in the brains of Alzheimer's disease (AD), Lewy body dementia …
Evaluation of N-and O-Linked Indole Triazines for a Dual Effect on α-Synuclein and Tau Aggregation
E Ramirez, SK Ganegamage, S Min… - ACS Chemical …, 2023 - ACS Publications
Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder underlying
dementia in the geriatric population. AD manifests by two pathological hallmarks …
dementia in the geriatric population. AD manifests by two pathological hallmarks …
Evaluation of Alpha-Synuclein and Tau Antiaggregation Activity of Urea and Thiourea-Based Small Molecules for Neurodegenerative Disease Therapeutics
Alzheimer's disease (AD) and Parkinson's disease (PD) are multifactorial, chronic diseases
involving neurodegeneration. According to recent studies, it is hypothesized that the …
involving neurodegeneration. According to recent studies, it is hypothesized that the …
[HTML][HTML] Discovery of small molecule benzothiazole and indole derivatives tackling tau 2N4R and α-synuclein fibrils
AA Elbatrawy, TA Ademoye, H Alnakhala… - Bioorganic & medicinal …, 2024 - Elsevier
Tau and α-synuclein aggregates are the main histopathological hallmarks present in
Alzheimer's disease (AD), Parkinson's disease (PD), and other neurodegenerative …
Alzheimer's disease (AD), Parkinson's disease (PD), and other neurodegenerative …
[HTML][HTML] Discovery of 4-aminoindole carboxamide derivatives to curtail alpha-synuclein and tau isoform 2N4R oligomer formation
E Ramirez, S Min, SK Ganegamage, K Shimanaka… - Results in chemistry, 2023 - Elsevier
Alzheimer's disease (AD) is a multifactorial, chronic neurodegenerative disease
characterized by the presence of extracellular β-amyloid (Aβ) plaques, intraneuronal …
characterized by the presence of extracellular β-amyloid (Aβ) plaques, intraneuronal …
1,4-Diurea- and 1,4-Dithiourea-Substituted Aromatic Derivatives Selectively Inhibit α-Synuclein Oligomer Formation In Vitro
SK Ganegamage, E Ramirez, H Alnakhala… - ACS …, 2023 - ACS Publications
Parkinson's disease (PD) is the second most common neurodegenerative disease, affecting
the elderly population worldwide. In PD, the misfolding of α-synuclein (α-syn) results in the …
the elderly population worldwide. In PD, the misfolding of α-synuclein (α-syn) results in the …
Sulfonamide Derivatives: Recent Compounds with Potent Anti-alzheimer's Disease Activity
MC Egbujor - Central Nervous System Agents in Medicinal …, 2024 - ingentaconnect.com
Facile synthetic procedures and broad spectrum of biological activities are special attributes
of sulfonamides. Sulfonamide derivatives have demonstrated potential as a class of …
of sulfonamides. Sulfonamide derivatives have demonstrated potential as a class of …
EVALUATION OF AMINOINDOLE CARBOXAMIDES AND TRIAZINES AS POTENTIAL ANTI-AGGREGATION AGENTS OF PROTEIN MISFOLDING DISEASES
E Ramirez - 2024 - hammer.purdue.edu
My research projects focuses on the dual targeting of small molecules to abrogate aberrant
α-syn, tau (2N4R), and p-tau (1N4R) aggregation and to reduce the spread of AD and …
α-syn, tau (2N4R), and p-tau (1N4R) aggregation and to reduce the spread of AD and …